Literature DB >> 12635134

Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas.

Hiroshi Kawachi1, Touichiro Takizawa, Yoshinobu Eishi, Shinichiro Shimizu, Jiro Kumagai, Nobuaki Funata, Morio Koike.   

Abstract

Differentiated gastric carcinoma (DGC) corresponds roughly to the intestinal type of gastric carcinoma described by Laurén. It has been suggested that DGCs arise from intestinalized gastric mucosa, but recent findings regarding their mucin expression do not support this hypothesis. To evaluate the histogenetic relationship between DGCs and intestinal metaplasia, lesions that are as small as possible should be examined. Twenty-five DGCs, ranging in their greatest dimension from 0.4 to 2.7 mm, were collected and divided into two groups by size. Group A consisted of 13 lesions less than 1.4 mm across, and group B of 12 lesions 1.4 mm or more. The presence of mucin and a brush border was assessed by immunostaining with antibodies against human gastric mucin, pyloric-gland-type mucin, Muc-2 glycoprotein, and CD10 antigen, and the lesions were classified as having the gastric phenotype (G-type), intestinal phenotype (I-type), mixed gastric and intestinal phenotype (M-type), or null phenotype (N-type). Thirteen (52%) of the 25 lesions were N-type, 5 (20%) lesions were G-type, 5 (20%) were I-type, and 2 (8%) were M-type. Group A had a larger proportion of N-type lesions than B (10/13, or 77%, vs. 3/12, or 25%; p = 0.027, chi-square test for proportions). Group B had a larger proportion of G-type lesions than A (5/12, or 42%, vs. 0/13, or 0%; p = 0.033). The phenotypes of the carcinomas and their surrounding mucosa were unrelated. Therefore, DGCs may arise from gastric mucosa affected by intestinal metaplasia or not, without having either the gastric or intestinal phenotype. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635134     DOI: 10.1002/path.1323

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Rita Rani Barua; Hiroshi Uozaki; Ja-Mun Chong; Tetsuo Ushiku; Rumi Hino; Moon-Sung Chang; Hideo Nagai; Masashi Fukayama
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.

Authors:  Mami Mihara; Yukinari Yoshida; Tetsuya Tsukamoto; Ken-ichi Inada; Yukihiro Nakanishi; Yukiko Yagi; Kohzoh Imai; Takashi Sugimura; Masae Tatematsu; Toshikazu Ushijima
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

3.  "Crawling-type" adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma.

Authors:  Naoko Okamoto; Hiroshi Kawachi; Tatsuya Yoshida; Keisuke Kitagaki; Masaki Sekine; Kazuyuki Kojima; Tatsuyuki Kawano; Yoshinobu Eishi
Journal:  Gastric Cancer       Date:  2012-08-04       Impact factor: 7.370

4.  Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Xueyuan Cao; Takafumi Otsuka; Seiji Ito; Emiko Takahashi; Shigeo Nakamura; Tsuneya Nakamura; Yoshitaka Yamamura; Masae Tatematsu
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

5.  Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach.

Authors:  Harunari Tanaka; Tetsuya Tsukamoto; Tsutomu Mizoshita; Ken-ichi Inada; Naotaka Ogasawara; Xueyuan Cao; Sosuke Kato; Takashi Joh; Masae Tatematsu
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

6.  Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.

Authors:  Koji Domori; Ken Nishikura; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

7.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

8.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

9.  Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases.

Authors:  Rie Kakinoki; Ryoji Kushima; Akiko Matsubara; Yasuharu Saito; Hidetoshi Okabe; Yoshihide Fujiyama; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2008-08-16       Impact factor: 3.199

10.  Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling.

Authors:  Aya Shinozaki; Tetsuo Ushiku; Teppei Morikawa; Rumi Hino; Takashi Sakatani; Hiroshi Uozaki; Masashi Fukayama
Journal:  J Histochem Cytochem       Date:  2009-04-27       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.